UK Biobank Reopens After a Leak That Exposed AI's Privacy Problem
UK Biobank's Research Analysis Platform reopens this September after a data security incident, and a 2026 study shows why AI is quietly eroding old promises of genetic anonymity.
The EU AI Act's Big Deadline Just Passed — and Drug Discovery Got a Reprieve
August 2, 2026 was supposed to be the day the EU AI Act's toughest rules hit high-risk systems. Then the Digital Omnibus moved the goalposts. Here's what actually changed, and what it means for AI in drug discovery.